EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cell Type Distribution of Intrathecal Antisense Oligonucleotide Activity in Deep Brain Regions of Non-Human Primates

Jeannine A Frei, Juliana E Gentile iD, Yuan Lian, Meredith A Mortberg, Juliana Capitanio, Paymaan Jafar-Nejad, Sonia M Vallabh, Hien T Zhao, Eric Vallabh Minikel

Nucleic Acid Therapeutics · 2025

DOI: 10.1177/21593337251371594 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, 2025. Verfasst von Jeannine A Frei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Program in Brain Health, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Oligonucleotides, Antisense, RNA, Long Noncoding, Brain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intrathecally administered RNase H1-active gapmer antisense oligonucleotides (ASOs) are promising therapeutics for brain diseases where lowering the expression of one target gene is expected to be therapeutically beneficial. Such ASOs are active, to varying degrees, across most or all cell types in the cortex and cerebellum of mouse and non-human primate (NHP) brain regions with substantial drug accumulation. Intrathecally delivered ASOs, however, exhibit a gradient of exposure across the brain, with more limited drug accumulation and weaker target engagement in deep brain regions of NHP. Here, we profiled the activity of a tool, ASO, against Malat1 in three deep brain regions of NHP: thalamus, caudate, and putamen. All neuronal subtypes exhibited knockdown similar to, or deeper than, the bulk tissue. Among non-neuronal cells, knockdown was deepest in microglia and weakest in endothelial stalk. Overall, we observed broad target engagement across all cell types detected, supporting the relevance of intrathecal ASOs to diseases with deep brain involvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oligonucleotides, AntisenseRNA, Long NoncodingBrainAnimalsMiceRibonuclease HInjections, SpinalNeuronsHumansThalamusPutamenCaudate NucleusMaleMicroglia

Stichwörter der Autor:innen

antisense oligonucleotidebrainnon-human primatesingle-cell sequencing

Substanzen

Oligonucleotides, AntisenseRNA, Long NoncodingRibonuclease Hribonuclease HI

Autor:innen und Institutionen

  • Program in Brain Health, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Ionis Pharmaceuticals, Carlsbad, California, USA.
  • McCance Center for Brain Health and Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
  • Prion Alliance, Cambridge, Massachusetts, USA.

ORCID-Profile: Juliana E Gentile

Zitieren

APA

Frei, J. A., Gentile, J. E., Lian, Y., Mortberg, M. A., Capitanio, J., Jafar-Nejad, P., Vallabh, S. M., Zhao, H. T., & Minikel, E. V. (2025). Cell Type Distribution of Intrathecal Antisense Oligonucleotide Activity in Deep Brain Regions of Non-Human Primates. Nucleic Acid Therapeutics. https://doi.org/10.1177/21593337251371594

Vancouver

Frei JA, Gentile JE, Lian Y, Mortberg MA, Capitanio J, Jafar-Nejad P, et al. Cell Type Distribution of Intrathecal Antisense Oligonucleotide Activity in Deep Brain Regions of Non-Human Primates. Nucleic Acid Therapeutics. 2025. doi:10.1177/21593337251371594

BibTeX
@article{Frei2025,
  author = {Frei, Jeannine A and Gentile, Juliana E and Lian, Yuan and Mortberg, Meredith A and Capitanio, Juliana and Jafar-Nejad, Paymaan and Vallabh, Sonia M and Zhao, Hien T and Minikel, Eric Vallabh},
  title = {Cell Type Distribution of Intrathecal Antisense Oligonucleotide Activity in Deep Brain Regions of Non-Human Primates},
  journal = {Nucleic Acid Therapeutics},
  year = {2025},
  doi = {10.1177/21593337251371594}
}
Kostenlos starten →